Monitoring Side-Effects of Clozapine Treatment

Clozapine is an atypical antipsychotic medication used to treat schizophrenia and psychosis in Parkinson’s disease. However, it can cause side-effects such as neutropenia and agranulocytosis, making it crucial to monitor the full blood count and white cells of patients on clozapine treatment. Other potential side-effects include extrapyramidal symptoms, tachycardia, arrhythmias, myocarditis, cardiomyopathy, hyperglycaemia, hypersalivation, constipation, anorexia, speech disorders, and urinary incontinence. However, measuring PT and PTT, haloperidol levels, clozapine levels, or blood electrolytes is not relevant to monitoring the side-effects of clozapine treatment.

This child has an infantile haemangioma, a benign lesion caused by abnormal vessel growth in the skin and deeper structures. These lesions usually appear shortly after birth and can grow rapidly in the first 3 months of life, peaking around the fifth month before regressing spontaneously. The haemangioma in this case is located in the posterior neck triangle and is asymptomatic, so medical photography will be taken and the child will be reassessed in 3 months. Treatment is only necessary if the haemangioma is troublesome, symptomatic, or affecting deeper structures. The first-line treatment is oral propranolol, but topical b blockers can be used if necessary. Surgery is reserved for rapidly evolving haemangiomas that are compressing vital structures or affecting essential functions. Topical timolol can also be used with caution if oral b blockers are not tolerated.

Understanding and Managing Pes Planovalgus

Pes planovalgus, also known as flat foot, is a common condition characterized by a decrease in the medial longitudinal arch with a valgus hindfoot and forefoot abduction with weight-bearing. While most cases resolve spontaneously, some individuals may experience arch or pretibial pain. However, asymptomatic patients can be reassured that the arch will normally develop with age.

Non-operative management is typically recommended, with symptomatic patients finding relief with athletic heels or orthotics such as heel cups. Surgical intervention, such as Achilles tendon or gastrocnemius fascia lengthening or calcaneal lengthening osteotomy, is reserved for chronic, painful cases that have failed non-operative therapy. Bed rest and partial weight-bearing are not indicated in the treatment of pes planovalgus.

Overall, understanding and managing pes planovalgus involves proper diagnosis, reassurance for asymptomatic patients, and appropriate non-operative or surgical intervention for symptomatic cases.

Caution should be exercised when using metformin in patients with acute kidney injury due to its potential to cause lactic acidosis. In such cases, it is recommended to discontinue nephrotoxic medications like NSAIDs, diuretics, and ACE inhibitors. Although lactic acidosis is rare, it is still important to consider it in exams. Direct oral anticoagulants may increase the risk of bleeding due to accumulation, but their dosage can be adjusted without discontinuing them entirely. Statins can be continued with close monitoring unless the AKI is caused by rhabdomyolysis or unexplained muscle pains. Bisoprolol is not directly harmful to the kidneys, but it may be withheld in severe AKI to avoid reducing kidney perfusion due to hypotension. However, in this case, the patient is not hypotensive, so immediate discontinuation is not necessary.

Metformin is a medication commonly used to treat type 2 diabetes mellitus. It belongs to a class of drugs called biguanides and works by activating the AMP-activated protein kinase (AMPK), which increases insulin sensitivity and reduces hepatic gluconeogenesis. Additionally, it may decrease the absorption of carbohydrates in the gastrointestinal tract. Unlike other diabetes medications, such as sulphonylureas, metformin does not cause hypoglycemia or weight gain, making it a first-line treatment option, especially for overweight patients. It is also used to treat polycystic ovarian syndrome and non-alcoholic fatty liver disease.

While metformin is generally well-tolerated, gastrointestinal side effects such as nausea, anorexia, and diarrhea are common and can be intolerable for some patients. Reduced absorption of vitamin B12 is also a potential side effect, although it rarely causes clinical problems. In rare cases, metformin can cause lactic acidosis, particularly in patients with severe liver disease or renal failure. However, it is important to note that lactic acidosis is now recognized as a rare side effect of metformin.

There are several contraindications to using metformin, including chronic kidney disease, recent myocardial infarction, sepsis, acute kidney injury, severe dehydration, and alcohol abuse. Additionally, metformin should be discontinued before and after procedures involving iodine-containing x-ray contrast media to reduce the risk of contrast nephropathy.

When starting metformin, it is important to titrate the dose slowly to reduce the incidence of gastrointestinal side effects. If patients experience intolerable side effects, modified-release metformin may be considered as an alternative.

Liver Tumours: Types, Risk Factors, and Diagnostic Methods

Liver tumours are abnormal growths that develop in the liver. The most common primary liver tumour is hepatocellular carcinoma (HCC), which is often associated with hepatitis B infection, cirrhosis, male gender, and increasing age. Chronic hepatitis B is the major risk factor worldwide, while hepatitis C is the major risk factor in Europe. Patients with underlying cirrhosis may present with decompensation of liver disease, such as ascites, jaundice, worsening liver function tests, and variceal haemorrhage. Examination may reveal hepatomegaly or a right hypochondrial mass. Vascularity of the tumour may result in an audible bruit on auscultation.

Diagnostic methods for liver tumours include increased α-fetoprotein, which is produced by 60% of HCCs. Ultrasound scanning will reveal focal lesions and may also show involvement of the portal vein. Helical triple-phase computed tomography (CT) scanning will identify HCC due to its hypervascular nature. Alternatively, magnetic resonance imaging (MRI) may be used.

Other types of liver tumours include fibrosarcoma, which is an extremely rare primary tumour of the liver, cholangiocarcinoma, which are usually adenocarcinomas and are the second most common primary tumour of the hepatobiliary system, affecting biliary ducts, hepatoblastoma, which is a liver tumour that typically presents in childhood, in the first 3 years of life, and leiomyosarcoma, which is another rare primary tumour of the liver. Leiomyosarcoma is thought to affect women more than men and typically seems to present later in life, in the fifth and sixth decades of life. However, greater understanding of the epidemiology of these rare tumours is required.

Anal cancer is primarily caused by the human papillomavirus (HPV), with approximately 90% of cases being linked to this viral infection. While being on immunosuppressive medication can increase the risk of anal cancer, this is believed to be due to the higher likelihood of contracting HPV. HIV infection has also been associated with anal cancer, but this is thought to be a result of the virus weakening the immune system and making it more difficult for the body to fight off HPV. Men who have sex with men are also at a higher risk of developing anal cancer, but this is likely due to their increased risk of contracting HPV.

Understanding Anal Cancer: Definition, Epidemiology, and Risk Factors

Anal cancer is a type of malignancy that occurs exclusively in the anal canal, which is bordered by the anorectal junction and the anal margin. The majority of anal cancers are squamous cell carcinomas, but other types include melanomas, lymphomas, and adenocarcinomas. The incidence of anal cancer is relatively rare, with an annual rate of about 1.5 in 100,000 in the UK. However, the incidence is increasing, particularly among men who have sex with men, due to widespread infection by human papillomavirus (HPV).

There are several risk factors associated with anal cancer, including HPV infection, anal intercourse, a high lifetime number of sexual partners, HIV infection, immunosuppressive medication, a history of cervical cancer or cervical intraepithelial neoplasia, and smoking. Patients typically present with symptoms such as perianal pain, perianal bleeding, a palpable lesion, and faecal incontinence.

To diagnose anal cancer, T stage assessment is conducted, which includes a digital rectal examination, anoscopic examination with biopsy, and palpation of the inguinal nodes. Imaging modalities such as CT, MRI, endo-anal ultrasound, and PET are also used. The T stage system for anal cancer is described by the American Joint Committee on Cancer and the International Union Against Cancer. It includes TX primary tumour cannot be assessed, T0 no evidence of primary tumour, Tis carcinoma in situ, T1 tumour 2 cm or less in greatest dimension, T2 tumour more than 2 cm but not more than 5 cm in greatest dimension, T3 tumour more than 5 cm in greatest dimension, and T4 tumour of any size that invades adjacent organ(s).

In conclusion, understanding anal cancer is crucial in identifying the risk factors and symptoms associated with this type of malignancy. Early diagnosis and treatment can significantly improve the prognosis and quality of life for patients.

The presence of the ‘snowstorm’ sign on ultrasound of axillary lymph nodes is indicative of extracapsular breast implant rupture. This occurs when silicone leaks out of the implant and travels through the lymphatic system, resulting in the ‘snowstorm appearance’ in both the breast and lymph nodes. The absence of infection or systemic illness suggests that an abscess is not the cause. While the presence of an axillary lump with any breast change raises suspicion of malignancy, implant rupture is the more probable diagnosis. To confirm whether it is LC, DC, or lymphoma, a biopsy for histology would be necessary.

Non-Malignant Breast Conditions

Duct ectasia is a common condition that affects up to 25% of normal female breasts. It is a variant of breast involution and is not the same as periductal mastitis. Patients with duct ectasia typically present with nipple discharge, which may be from single or multiple ducts and is often thick and green. This condition is usually seen in women over the age of 50.

Periductal mastitis, on the other hand, is more commonly seen in younger women and may present with features of inflammation, abscess, or mammary duct fistula. It is strongly associated with smoking and is usually treated with antibiotics. An abscess will require drainage.

Intraductal papilloma is a growth of papilloma in a single duct and usually presents with clear or blood-stained discharge originating from a single duct. There is no increase in the risk of malignancy.

Breast abscesses are common in lactating women and are usually caused by Staphylococcus aureus infection. On examination, there is usually a tender fluctuant mass. Treatment is with antibiotics and ultrasound-guided aspiration. Overlying skin necrosis is an indication for surgical debridement, which may be complicated by the development of a subsequent mammary duct fistula.

Tuberculosis is a rare condition in western countries and is usually secondary TB. It affects women later in their childbearing period, and a chronic breast or axillary sinus is present in up to 50% of cases. Diagnosis is by biopsy culture and histology.

Managing Diarrhoea and Vomiting in Children

Diarrhoea and vomiting are common in young children, with rotavirus being the most common cause of gastroenteritis in the UK. According to the 2009 NICE guidelines, diarrhoea usually lasts for 5-7 days and stops within 2 weeks, while vomiting usually lasts for 1-2 days and stops within 3 days. When assessing hydration status, NICE recommends using normal, dehydrated, or shocked categories instead of the traditional mild, moderate, or severe categories.

Children younger than 1 year, especially those younger than 6 months, infants who were of low birth weight, and those who have passed six or more diarrhoeal stools in the past 24 hours or vomited three times or more in the past 24 hours are at an increased risk of dehydration. Additionally, children who have not been offered or have not been able to tolerate supplementary fluids before presentation, infants who have stopped breastfeeding during the illness, and those with signs of malnutrition are also at risk.

If clinical shock is suspected, children should be admitted for intravenous rehydration. For children without evidence of dehydration, it is recommended to continue breastfeeding and other milk feeds, encourage fluid intake, and discourage fruit juices and carbonated drinks. If dehydration is suspected, give 50 ml/kg low osmolarity oral rehydration solution (ORS) solution over 4 hours, plus ORS solution for maintenance, often and in small amounts. It is also important to continue breastfeeding and consider supplementing with usual fluids, including milk feeds or water, but not fruit juices or carbonated drinks.

In terms of diagnosis, NICE suggests doing a stool culture in certain situations, such as when septicaemia is suspected, there is blood and/or mucous in the stool, or the child is immunocompromised. A stool culture should also be considered if the child has recently been abroad, the diarrhoea has not improved by day 7, or there is uncertainty about the diagnosis of gastroenteritis. Features suggestive of hypernatraemic dehydration include jittery movements, increased muscle tone, hyperreflexia, convulsions, and drowsiness or coma.

Placenta increta is a condition where the chorionic villi, which are normally found in the endometrium, invade the myometrium. This can lead to significant bleeding during vaginal delivery. Placenta increta is more serious than placenta accreta, where the chorionic villi attach to the myometrium but do not invade it, but less severe than placenta percreta, where the chorionic villi invade the perimetrium.

Understanding Placenta Accreta

Placenta accreta is a condition where the placenta attaches to the myometrium instead of the decidua basalis, which can lead to postpartum hemorrhage. This condition is caused by a defective decidua basalis. There are three types of placenta accreta, which are categorized based on the degree of invasion. The first type is accreta, where the chorionic villi attach to the myometrium. The second type is increta, where the chorionic villi invade into the myometrium. The third type is percreta, where the chorionic villi invade through the perimetrium.

There are certain risk factors that increase the likelihood of developing placenta accreta, such as having a previous caesarean section or placenta previa. It is important for healthcare providers to be aware of these risk factors and monitor patients closely during pregnancy and delivery. Early detection and management of placenta accreta can help prevent complications and ensure the best possible outcome for both the mother and baby.

Managing Hypertension in Phaeochromocytoma: The Role of α-Adrenoceptor Antagonists

Phaeochromocytoma is a rare tumour that can cause life-threatening hypertension due to excessive production of catecholamines. Diagnosis is made by measuring creatinine, total catecholamines and metanephrines in a 24-hour urine sample. Treatment involves laparoscopic adrenalectomy and pre-operative management of hypertension with an α-adrenoceptor antagonist such as phenoxybenzamine. This irreversible antagonist induces vasodilation and a drop in blood pressure, but can cause reflex tachycardia and other side-effects. Administration of a β-adrenoceptor antagonist without adequate α-blockade can lead to a hypertensive crisis. Reversible α-adrenoceptor antagonists offer less effective blockade, while reversible α-adrenoceptor agonists can worsen hypertension.